Texas 2013 - 83rd Regular

Texas Senate Bill SB1645

Voted on by Senate
 
Out of House Committee
 
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the addition of certain substances to Penalty Group 3 of the Texas Controlled Substances Act; providing penalties.

Impact

The amendment to the Controlled Substances Act signifies a significant shift in Texas law towards a more stringent approach to drug-related offenses. By categorizing new chemical compounds into Penalty Group 3, the bill increases the legal repercussions for individuals found in possession of these substances. This could have considerable implications for law enforcement, judicial processes, and public health initiatives, as it may lead to a larger number of arrests and prosecutions for related offenses. Furthermore, it reflects a growing acknowledgment within the legislature of the need to combat the rising trend of substance abuse amid communities in Texas.

Summary

SB1645 seeks to amend the Texas Controlled Substances Act by introducing additional substances to Penalty Group 3, which is designated for drugs with a potential for abuse. The bill specifies several chemical compounds, including various stimulants, depressants, and anabolic steroids, that are now categorized under this penalty group, thus making possession and distribution of these substances subject to stricter legal penalties. This legislative change aims to address growing concerns around substance abuse in the state and enhance public safety by tightening controls around these potentially harmful substances.

Sentiment

General sentiment surrounding SB1645 appears to be supportive among lawmakers who prioritize public health and safety. Proponents of the bill argue that it is a necessary step forward in combating drug abuse and protecting vulnerable populations. Conversely, some stakeholders have expressed concern that increased regulations may not address the underlying issues of addiction and could lead to negative social consequences. There is a call for balancing strict penalties with preventive measures and support for rehabilitation rather than just punitive actions.

Contention

Notable points of contention revolve around the effectiveness of the bill in genuinely addressing drug abuse issues. Critics question whether merely adding substances to a penalty group is sufficient to tackle the complexities of substance dependency and recovery. Additionally, there are concerns regarding the possible overreach of the state's authority in personal health decisions, particularly in light of the legislative push towards stricter laws governing medications and substances that individuals may choose to use.

Companion Bills

No companion bills found.

Similar Bills

TX HB470

Relating to the addition of Salvia divinorum and its derivatives and extracts to Penalty Group 3 of the Texas Controlled Substances Act.

TX HB124

Relating to the addition of Salvia divinorum and its derivatives and extracts to Penalty Group 3 of the Texas Controlled Substances Act.

IL HB0077

CONTROLLED SUB-XYLAZINE

IL HB3129

KRATOM-SCHEDULE III

TX HB2671

Relating to the placement of certain substances in Penalty Groups 1 and 3 of the Texas Controlled Substances Act and the prosecution of criminal offenses involving certain substances listed in Penalty Groups 1, 2, and 3 of that Act.

TX SB2176

Relating to the placement of certain substances in Penalty Groups 1 and 3 of the Texas Controlled Substances Act for the purposes of prosecution of criminal offenses involving those substances.

TX HB1011

Relating to the addition of certain synthetic derivatives of marihuana and Saliva divinorum and its derivatives and extracts to the Texas Controlled Substances Act.

MT HB41

Generally revise dangerous drug schedule